Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
01 2023
Historique:
revised: 13 10 2022
received: 17 08 2022
accepted: 26 10 2022
pubmed: 5 11 2022
medline: 11 1 2023
entrez: 4 11 2022
Statut: ppublish

Résumé

Breast milk has been found to inhibit coronavirus infection, while the key components and mechanisms are unknown. We aimed to determine the components that contribute to the antiviral effects of breastmilk and explore their potential mechanism. Lactoferrin (Lf) and milk fat globule membrane inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related coronavirus GX_P2V and transcription- and replication-competent SARS-CoV-2 virus-like particles in vitro and block viral entry into cells. We confirmed that bovine Lf (bLf) blocked the binding between human angiotensin-converting enzyme 2 and SARS-CoV-2 spike protein by combining receptor-binding domain (RBD). Importantly, bLf inhibited RNA-dependent RNA polymerase (RdRp) activity of both SARS-CoV-2 and SARS-CoV in vitro in the nanomolar range. So far, no biological macromolecules have been reported to inhibit coronavirus RdRp. Our result indicated that bLf plays a major role in inhibiting viral replication. bLf treatment reduced viral load in lungs and tracheae and alleviated pathological damage. Our study provides evidence that bLf prevents SARS-CoV-2 infection by combining SARS-CoV-2 spike protein RBD and inhibiting coronaviruses' RdRp activity, and may be a promising candidate for the treatment of coronavirus disease 2019.

Identifiants

pubmed: 36329614
doi: 10.1002/jmv.28281
pmc: PMC9878033
doi:

Substances chimiques

spike protein, SARS-CoV-2 0
Lactoferrin EC 3.4.21.-
Spike Glycoprotein, Coronavirus 0
Antiviral Agents 0
RNA-Dependent RNA Polymerase EC 2.7.7.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28281

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Chin Med J (Engl). 2020 May 5;133(9):1051-1056
pubmed: 32149769
J Immunol. 2016 Aug 1;197(3):899-909
pubmed: 27316687
Life Sci. 2018 Feb 15;195:61-64
pubmed: 29307524
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36):
pubmed: 34413211
Emerg Microbes Infect. 2021 Dec;10(1):317-330
pubmed: 33560940
Biometals. 2004 Jun;17(3):311-5
pubmed: 15222483
Signal Transduct Target Ther. 2020 Nov 24;5(1):275
pubmed: 33235188
Microorganisms. 2021 May 19;9(5):
pubmed: 34069681
Curr Opin Virol. 2021 Jun;48:73-81
pubmed: 33906125
Heliyon. 2021 Sep 28;7(9):e08087
pubmed: 34632151
J Virol. 2020 Oct 14;94(21):
pubmed: 32817221
Biochem J. 2021 Jul 16;478(13):2425-2443
pubmed: 34198323
Front Immunol. 2022 May 31;13:896068
pubmed: 35711421
Front Immunol. 2022 Apr 05;13:821730
pubmed: 35479098
Antiviral Res. 2020 Jun;178:104792
pubmed: 32272173
Nutrients. 2022 Jul 27;14(15):
pubmed: 35956266
Nutrients. 2021 Jan 23;13(2):
pubmed: 33498631
Nat Struct Mol Biol. 2021 Mar;28(3):319-325
pubmed: 33674802
Food Sci Nutr. 2020 Dec 19;9(1):25-35
pubmed: 33473267
J Dairy Sci. 2022 Apr;105(4):2791-2802
pubmed: 35221061
Nature. 2020 Aug;584(7819):154-156
pubmed: 32438371
PLoS Pathog. 2021 Mar 12;17(3):e1009439
pubmed: 33711082
mBio. 2021 Oct 26;12(5):e0234221
pubmed: 34700373
Signal Transduct Target Ther. 2022 May 3;7(1):146
pubmed: 35504917
Antiviral Res. 2014 Nov;111:13-22
pubmed: 25193851
Exploration (Beijing). 2022 Jul 21;:20210082
pubmed: 35941992
Nature. 2021 May;593(7859):418-423
pubmed: 33727703
Int J Environ Res Public Health. 2021 Oct 19;18(20):
pubmed: 34682731
Nature. 2020 Jul;583(7815):282-285
pubmed: 32218527
Virol J. 2021 Mar 29;18(1):66
pubmed: 33781287
Cell Rep. 2020 Jun 16;31(11):107774
pubmed: 32531208
Int J Antimicrob Agents. 2020 Sep;56(3):106118
pubmed: 32738305
J Hazard Mater. 2022 May 15;430:128414
pubmed: 35149493
J Med Virol. 2023 Jan;95(1):e28281
pubmed: 36329614
Nat Commun. 2021 Jan 12;12(1):279
pubmed: 33436624
J Dairy Sci. 2013 Jun;96(6):3488-97
pubmed: 23548280
Food Funct. 2018 Aug 15;9(8):4216-4222
pubmed: 29993054
Front Nutr. 2022 Jan 28;8:807284
pubmed: 35155526
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1470-1481
pubmed: 34677626
Nature. 2020 Sep;585(7826):588-590
pubmed: 32698190
Brief Bioinform. 2021 Nov 5;22(6):
pubmed: 34180984
Bioinformatics. 2014 Jun 15;30(12):1771-3
pubmed: 24532726
JAMA. 2020 Oct 6;324(13):1347-1348
pubmed: 32822495
J Virol. 2004 Aug;78(16):8701-8
pubmed: 15280478
J Virol. 2007 Apr;81(7):3051-7
pubmed: 17079323
SLAS Discov. 2020 Dec;25(10):1141-1151
pubmed: 32660307
Front Med (Lausanne). 2021 Sep 08;8:703950
pubmed: 34568367
mBio. 2020 Nov 12;11(6):
pubmed: 33184103
Nat Protoc. 2020 Nov;15(11):3699-3715
pubmed: 32978602
iScience. 2022 Apr 15;25(4):104136
pubmed: 35342878

Auteurs

Shi-Ting He (ST)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Hongbo Qin (H)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Lin Guan (L)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Ke Liu (K)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Bixia Hong (B)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Xiaoxu Zhang (X)

Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China.

Fuxing Lou (F)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Maochen Li (M)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Wei Lin (W)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Yangzhen Chen (Y)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Chengzhi He (C)

Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China.

Feitong Liu (F)

H&H Group, H&H Research, China Research and Innovation, Guangzhou, China.

Shanshan Lu (S)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Shengdong Luo (S)

The Fifth Medical Center, Chinese PLA People's Liberation Army General Hospital, Beijing, China.

Shaozhou Zhu (S)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Xiaoping An (X)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Lihua Song (L)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Huahao Fan (H)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Yigang Tong (Y)

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH